These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 26990531

  • 1. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
    Wiener A, Schippers A, Wagner N, Tacke F, Ostendorf T, Honke N, Tenbrock K, Ohl K.
    Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
    [Abstract] [Full Text] [Related]

  • 2. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, Tsai CY.
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [Abstract] [Full Text] [Related]

  • 3. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
    Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J, Pfeilschifter J, Young MF, Schaefer RM, Schaefer L.
    J Clin Invest; 2010 Dec; 120(12):4251-72. PubMed ID: 21084753
    [Abstract] [Full Text] [Related]

  • 4. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
    Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.
    J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
    [Abstract] [Full Text] [Related]

  • 5. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M, El-Gammasy T, Shaheen K, Shokr E.
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [Abstract] [Full Text] [Related]

  • 6. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 8. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Oct 01; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 9. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
    Xia W, Eltrich N, Vielhauer V.
    Front Immunol; 2024 Oct 01; 15():1377913. PubMed ID: 38799420
    [Abstract] [Full Text] [Related]

  • 10. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis.
    Steinmetz OM, Velden J, Kneissler U, Marx M, Klein A, Helmchen U, Stahl RA, Panzer U.
    Kidney Int; 2008 Aug 01; 74(4):448-57. PubMed ID: 18528326
    [Abstract] [Full Text] [Related]

  • 11. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
    Corneth OBJ, Schaper F, Luk F, Asmawidjaja PS, Mus AMC, Horst G, Heeringa P, Hendriks RW, Westra J, Lubberts E.
    Sci Rep; 2019 Mar 11; 9(1):4032. PubMed ID: 30858513
    [Abstract] [Full Text] [Related]

  • 12. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
    Heinrichs M, Ashour D, Siegel J, Büchner L, Wedekind G, Heinze KG, Arampatzi P, Saliba AE, Cochain C, Hofmann U, Frantz S, Campos Ramos G.
    Cardiovasc Res; 2021 Nov 22; 117(13):2664-2676. PubMed ID: 34048536
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May 22; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 14. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 May 22; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 15. Spin90 deficiency increases CXCL13-mediated B cell migration.
    Park SH, Kim HR, Jun CD, Song WK, Park SG.
    Scand J Immunol; 2014 Sep 22; 80(3):191-7. PubMed ID: 24965518
    [Abstract] [Full Text] [Related]

  • 16. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines.
    Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG.
    J Exp Med; 1999 Oct 18; 190(8):1123-34. PubMed ID: 10523610
    [Abstract] [Full Text] [Related]

  • 17. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
    Sáez de Guinoa J, Barrio L, Mellado M, Carrasco YR.
    Blood; 2011 Aug 11; 118(6):1560-9. PubMed ID: 21659539
    [Abstract] [Full Text] [Related]

  • 18. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP, Hajduczki A, Pampusch MS, Mwakalundwa G, Vargas-Inchaustegui DA, Rakasz EG, Connick E, Berger EA, Skinner PJ.
    Front Immunol; 2018 Aug 11; 9():492. PubMed ID: 29616024
    [Abstract] [Full Text] [Related]

  • 19. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Touré F.
    J Immunol; 2015 Apr 15; 194(8):3612-22. PubMed ID: 25762779
    [Abstract] [Full Text] [Related]

  • 20. Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses.
    Velaga S, Herbrand H, Friedrichsen M, Jiong T, Dorsch M, Hoffmann MW, Förster R, Pabst O.
    J Immunol; 2009 Mar 01; 182(5):2610-9. PubMed ID: 19234155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.